Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
publications [2023/09/08 11:06] afriaes [2023] |
publications [2024/02/13 15:59] ramirez [2024] |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== Publications ====== | ====== Publications ====== | ||
+ | ===== 2024 ===== | ||
+ | Mendes Pedro D, Paulo SE, Santos CM, Fonseca AB, [[people:jmelocristino|Melo-Cristino J]], Pereira AA, Caneiras C. 2024. Extensively drug-resistant //Pseudomonas aeruginosa//: clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care university hospital center in Portugal – A cross-sectional and retrospective observational study. Frontiers in Microbiology 15. //In press// | ||
+ | |||
+ | Bajanca-Lavado MP, Pinto M, Carvalho MD, Jantarada Domingos G, [[people:jmelocristino|Melo-Cristino J]]. 2024. Rare serotype c //Haemophilus influenzae// invasive isolate: characterization of the first case in Portugal. Eur J Clin Microbiol Infect Dis //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/38332396/|(PMID: 38332396)]] | ||
+ | |||
+ | [[people:anacosta|Silva-Costa C]], [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M.]] 2024. <fc #0000FF>//Streptococcus pneumoniae//</fc>, p. 1479–1490. In Tang, Y-W, Hindiyeh, MY, Liu, D, Sails, A, Spearman, P, Zhang, J-R (eds.), Molecular Medical Microbiology (Third Edition). Academic Press. [[https://doi.org/10.1016/B978-0-12-818619-0.00095-2|doi:10.1016/B978-0-12-818619-0.00095-2]][[https://www.sciencedirect.com/science/article/abs/pii/B9780128186190000952 | ||
+ | |Publisher site]] | ||
===== 2023 ===== | ===== 2023 ===== | ||
+ | [[people:anacosta|Silva-Costa C]], Gomes-Silva J, Santos A, [[people:ramirez|Ramirez M]], [[people:jmelocristino|Melo-Cristino J]], The Portuguese Group for the Study of Streptococcal Infections. 2023. <fc #0000FF>Adult non-invasive pneumococcal pneumonia in Portugal is dominated by serotype 3 and non-PCV13 serotypes 3-years after near universal PCV13 use in children</fc>. Frontiers in Public Health 11:1279656 [[https://www.ncbi.nlm.nih.gov/pubmed/38186693/|(PMID: 38186693)]] | ||
- | Gouveia C, Bajanca-Lavado MP, Mamede R, Araújo Carvalho A, Rodrigues F, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M.]], [[people:afriaes|Friães A]]. 2023. <fc #0000FF>Sustained increase of paediatric invasive //Streptococcus pyogenes// infections dominated by M1UK and diverse //emm//12 isolates, Portugal, September 2022 to May 2023.</fc> Eurosurveillance 28(36). [[http://www.ncbi.nlm.nih.gov/pubmed/37676143/|(PMID: 37676143)]] | + | Mendes G, Santos ML, Ramalho JF, Bruschy-Fonseca A, Lito L, Mendes-Pedro D, Duarte A, [[people:jmelocristino|Melo-Cristino J]], Caneiras C. 2023. <fc #0000FF>Genomic characterisation of a novel KPC-98-producing clinical //Klebsiella pneumoniae// strain conferring resistance to ceftazidime/avibactam</fc>. Int J Antimicrob Agents 62:107013. [[https://www.ncbi.nlm.nih.gov/pubmed/37875180/|(PMID: 37875180)]] |
+ | |||
+ | Grobusch MP, Ruiz Del Portal Luyten C, Visser BJ, de Jong HK, Goorhuis A, Hanscheid T. 2023. <fc #0000FF>Overcoming publication and dissemination bias in infectious diseases clinical trials</fc>. Lancet Infect Dis S1473-3099(23)00455–3. [[https://www.ncbi.nlm.nih.gov/pubmed/37837983/|(PMID: 37837983)]] | ||
+ | |||
+ | Gouveia C, Bajanca-Lavado MP, Mamede R, Araújo Carvalho A, Rodrigues F, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M.]], [[people:afriaes|Friães A]], Portuguese Group for the Study of Streptococcal Infections, Portuguese Study Group of Pediatric Invasive Streptococcal Disease. 2023. <fc #0000FF>Sustained increase of paediatric invasive //Streptococcus pyogenes// infections dominated by M1<sub>UK</sub> and diverse //emm//12 isolates, Portugal, September 2022 to May 2023.</fc> Eurosurveillance 28(36). [[https://www.ncbi.nlm.nih.gov/pubmed/37676143/|(PMID: 37676143)]] | ||
+ | |||
+ | Xie O, Morris JM, Hayes AJ, Towers RJ, Jespersen MG, Lees JA, Zakour NLB, Berking O, Baines SL, Carter GP, Tonkin-Hill G, Schrieber L, McIntyre L, Lacey JA, James TB, Sriprakash KS, Beatson SA, Hasegawa T, Giffard P, Steer AC, Batzloff MR, Beall BW, Pinho MD, [[people:ramirez|Ramirez M.]], Bessen DE, Dougan G, Bentley SD, Walker MJ, Currie BJ, Tong SYC, McMillan DJ, Davies MR. 2023. <fc #0000FF>Inter-species gene flow drives ongoing evolution of //Streptococcus pyogenes// and //Streptococcus dysgalactiae// subsp. //equisimilis//</fc>. bioRxiv [[https://doi.org/10.1101/2023.08.10.552873|(doi: 10.1101/2023.08.10.552873)]]. | ||
+ | |||
+ | Pinto Junior VL, Valadas E, Hanscheid T. 2023. <fc #0000FF>Combating vaccine hesitancy requires knowledge of misfortunes and controversies</fc>. Acta Med Port 36:537–540. [[https://pubmed.ncbi.nlm.nih.gov/37579748/|(PMID: 37579748)]] | ||
Riche CVW, Cassol R, Falci DR, [[people:ramirez|Ramirez M]], Dias CAG. 2023. <fc #0000FF>Epidemiology and risk factors for mortality among methicillin-resistant //Staphylococcus aureus// bacteremic patients in Southern Brazil</fc>. PLoS One 18:e0283774. [[https://pubmed.ncbi.nlm.nih.gov/37053222/|(PMID: 37053222)]] | Riche CVW, Cassol R, Falci DR, [[people:ramirez|Ramirez M]], Dias CAG. 2023. <fc #0000FF>Epidemiology and risk factors for mortality among methicillin-resistant //Staphylococcus aureus// bacteremic patients in Southern Brazil</fc>. PLoS One 18:e0283774. [[https://pubmed.ncbi.nlm.nih.gov/37053222/|(PMID: 37053222)]] | ||
+ | |||
+ | Marinho PF, Vieira SL, Carvalho TG, Peleteiro MC, Hanscheid T. 2023. <fc #0000FF>A novel and simple heat-based method eliminates the highly detrimental effect of xylene deparaffinization on acid-fast stains</fc>. Am J Clin Pathol 160:81–88. [[https://pubmed.ncbi.nlm.nih.gov/36897250/|(PMID: 36897250)]] | ||
+ | |||
+ | Bouchami O, Machado M, [[people:jcarrico|Carriço JA]], [[people:jmelocristino|Melo-Cristino J]], de Lencastre H, Miragaia M. 2023. <fc #0000FF>Spontaneous genomic variation as a survival strategy of nosocomial //Staphylococcus haemolyticus//</fc>. Microbiol Spectr 11:e0255222. [[https://pubmed.ncbi.nlm.nih.gov/36877037/|(PMID: 36877037)]] | ||
+ | |||
+ | Marinho PF, Hanscheid T. 2023. <fc #0000FF>A simple heat-based alternative method for deparaffinization of histological sections significantly improves acid-fast staining results for Mycobacteria in tissue</fc>. MethodsX 10:102079. [[https://pubmed.ncbi.nlm.nih.gov/36865652/|(PMID: 36865652)]] | ||
Schnyder JL, de Jong HK, Bache EB, van Hest RM, Schlagenhauf P, Borrmann S, Hanscheid T, Grobusch MP. 2023. <fc #0000FF>On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives</fc>. Travel Med Infect Dis 52: //In press// [[https://pubmed.ncbi.nlm.nih.gov/36526126/|(PMID: 36526126)]] | Schnyder JL, de Jong HK, Bache EB, van Hest RM, Schlagenhauf P, Borrmann S, Hanscheid T, Grobusch MP. 2023. <fc #0000FF>On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives</fc>. Travel Med Infect Dis 52: //In press// [[https://pubmed.ncbi.nlm.nih.gov/36526126/|(PMID: 36526126)]] | ||
===== 2022 ===== | ===== 2022 ===== | ||
- | Mendes CI, Vila-Cerqueira P, Motro Y, Moran-Gilad J, Carriço JA, [[people:ramirez|Ramirez M.]]. 2022. <fc #0000FF>LMAS: evaluating metagenomic short de novo assembly methods through defined communities</fc>. Gigascience 12:giac122. [[https://pubmed.ncbi.nlm.nih.gov/36576131/|(PMID: 36576131)]] | + | Mendes CI, Vila-Cerqueira P, Motro Y, Moran-Gilad J, [[people:jcarrico|Carriço JA]], [[people:ramirez|Ramirez M.]]. 2022. <fc #0000FF>LMAS: evaluating metagenomic short de novo assembly methods through defined communities</fc>. Gigascience 12:giac122. [[https://pubmed.ncbi.nlm.nih.gov/36576131/|(PMID: 36576131)]] |
Kalkman LC, Hänscheid T, Krishna S, Grobusch MP. 2022. <fc #0000FF>Fluid therapy in sepsis? Pathogen-specific perspectives</fc>. New Microbes New Infect 49–50:101035. [[https://pubmed.ncbi.nlm.nih.gov/36324876/|(PMID: 36324876)]] | Kalkman LC, Hänscheid T, Krishna S, Grobusch MP. 2022. <fc #0000FF>Fluid therapy in sepsis? Pathogen-specific perspectives</fc>. New Microbes New Infect 49–50:101035. [[https://pubmed.ncbi.nlm.nih.gov/36324876/|(PMID: 36324876)]] |